Discontinuation report OPTIMARK
| Report ID | 8842 |
| Drug Identification Number | 02242986 |
| Brand name | OPTIMARK |
| Common or Proper name | GADOVERSETAMIDE INJECTION |
| Company Name | LIEBEL-FLARSHEIM CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | GADOVERSETAMIDE |
| Strength(s) | 330.9MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 5, 10, 15, 20mL vials |
| ATC code | V08CA |
| ATC description | MAGNETIC RESONANCE IMAGING CONTRAST MEDIA |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2017-12-31 |
| Actual discontinuation date | 2018-03-23 |
| Remaining supply date | 2018-03-23 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7500 TRANSCANADA HIGHWAY POINTE-CLAIRE, QUEBEC CANADA H9R 5H8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2018-03-28 | French | Compare |
| v8 | 2018-03-28 | English | Compare |
| v7 | 2018-03-28 | French | Compare |
| v6 | 2018-03-28 | English | Compare |
| v5 | 2018-03-28 | English | Compare |
| v4 | 2018-01-22 | French | Compare |
| v3 | 2018-01-22 | English | Compare |
| v2 | 2017-05-03 | French | Compare |
| v1 | 2017-05-03 | English | Compare |
Showing 1 to 9 of 9